GABRIEL SIMS: Open Payments
NPI 1659751279 · RICHLAND, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,234 in 60 payments from 14 companies in 2025. Trend: 2023 $509 · 2024 $730 · 2025 $1,234
Food & beverage: $1,234
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $323 |
| AstraZeneca Pharmaceuticals LP | 11 | $192 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $116 |
| PFIZER INC. | 6 | $115 |
| Novo Nordisk Inc | 6 | $113 |
| Corcept Therapeutics | 4 | $112 |
| Xeris Pharmaceuticals, Inc. | 3 | $62 |
| Exact Sciences Corporation | 2 | $50 |
| Fresenius Kabi USA, LLC | 2 | $41 |
| Inspire Medical Systems, Inc. | 1 | $35 |
Products named: QULIPTA, UBRELVY, CAPLYTA, NURTEC ODT, Korlym, RECORLEV, Wegovy, Rybelsus.
Industry payments across WA — which companies pay providers there.
